分组1 - Revvity (RVTY) reported quarterly earnings of $1.7 per share, exceeding the Zacks Consensus Estimate of $1.63 per share, and up from $1.42 per share a year ago, representing an earnings surprise of +4.29% [1] - The company posted revenues of $772.06 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.02%, and an increase from $729.37 million year-over-year [2] - Revvity has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has gained approximately 12.5% since the beginning of the year, compared to the S&P 500's gain of 1.4% [3] - The current consensus EPS estimate for the upcoming quarter is $1.11 on revenues of $679.95 million, and for the current fiscal year, it is $5.32 on revenues of $2.94 billion [7] - The Zacks Industry Rank indicates that the Medical Services sector is currently in the bottom 27% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Charles River Laboratories (CRL) due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Charles River is expected to report quarterly earnings of $2.06 per share, reflecting a year-over-year decrease of 9.3% [3]. - Revenues are projected to be $935.05 million, down 7.6% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.82% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Charles River is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.52% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with positive readings being more predictive of earnings beats [6][7]. - A positive Earnings ESP combined with a strong Zacks Rank increases the likelihood of a positive surprise, but Charles River's current Zacks Rank is 3, making it difficult to predict an earnings beat [8][11]. Historical Performance - In the last reported quarter, Charles River exceeded the expected earnings of $2.50 per share, achieving $2.66, resulting in a surprise of +6.40% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates four times [13]. Industry Comparison - Premier, Inc. (PINC), another player in the medical services industry, is expected to report earnings of $0.31 per share, indicating a year-over-year decline of 43.6% [17]. - Premier's revenues are expected to be $238.88 million, down 30.3% from the previous year, but it has an Earnings ESP of 13.82% and a Zacks Rank of 2, suggesting a likely earnings beat [18].